AlphaFold predicted structure
DHFR · P00374

Mean pLDDT
96.1/ 100
Very high
187 residues
Confidence breakdown
- Very high(≥ 90)96%
- Confident(70–90)3%
- Low(50–70)1%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dihydrofolate reductase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Cerebral folate deficiency
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalNeurotransmitter disorders
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomal+4 more panels — install the extension to see the full list inline on any page.
constitutional megaloblastic anemia with severe neurologic disease
rheumatoid arthritis
non-small cell lung carcinoma
acute lymphoblastic leukemia
psoriasis
breast cancer
mesothelioma
juvenile idiopathic arthritis
malignant pleural mesothelioma
hereditary neoplastic syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dihydrofolate reductase
Catalyzes the reduction of 7,8-dihydrofolate (DHF) to 5,6,7,8-tetrahydrofolate in a NADPH-dependent manner (PubMed:12096917, PubMed:15039552, PubMed:17569517, PubMed:19196009, PubMed:19478082, PubMed:21876184, PubMed:9719595). Key enzyme in folate metabolism. Contributes to the nuclear and mitochondrial de novo thymidylate biosynthesis pathway (PubMed:21876188, PubMed:22235121). Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFR2
Curated MONDO disease pages that list DHFR among their top associated genes.
DHFR · P00374

Mean pLDDT
96.1/ 100
Very high
187 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0